Related Experiment Video

Updated: May 21, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

[Chronic rheumatic manifestations following chikungunya virus infection: clinical description and therapeutic

A Ribéra1, I Degasne, M C Jaffar Bandjee

  • 1Service de Rhumatologie, CHU Réunion Nord Saint Denis, France. anne.ribera@orange.fr

Medecine Tropicale : Revue Du Corps De Sante Colonial
|June 15, 2012
PubMed

Insights

Chikungunya virus infection can lead to long-term rheumatic issues. Patients with acute phases lasting over three weeks may benefit from early rheumatologic evaluation and potential immunosuppressive treatment.

Area of Science:

  • Virology
  • Rheumatology
  • Epidemiology

Context:

  • The 2005-2006 chikungunya virus epidemic on Reunion Island impacted over 250,000 individuals.
  • The outbreak provided extensive data on the acute phase of chikungunya virus infection and its rheumatic manifestations.

Purpose:

  • To enhance understanding and management of chronic rheumatic conditions following chikungunya virus infection.
  • To identify risk factors for developing persistent inflammatory polyarthritis after chikungunya virus infection.

Summary:

  • A study of 360 patients revealed that an acute phase of chikungunya virus infection exceeding three weeks increases the risk of inflammatory polyarthritis.
  • Early rheumatologic evaluation at three months is recommended for at-risk patients.
  • Consideration of immunosuppressive therapy, such as methotrexate, may be beneficial for preventing chronic symptoms.

Impact:

  • Informs clinical practice regarding the long-term management of chikungunya virus-related rheumatic diseases.
  • Highlights the importance of timely specialist evaluation for patients with prolonged acute chikungunya symptoms.
  • Contributes to the development of strategies for preventing chronic rheumatic manifestations post-chikungunya infection.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...